CRUS vs MCHPP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

CRUS

57.7
AI Score
VS
CRUS Wins

MCHPP

46.3
AI Score

Investment Advisor Scores

CRUS

58score
Recommendation
STRONG BUY

MCHPP

46score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CRUS MCHPP Winner
Forward P/E 13.7741 0 Tie
PEG Ratio 9.3455 0 Tie
Revenue Growth 12.9% 38.0% MCHPP
Earnings Growth 28.9% -81.6% CRUS
Tradestie Score 57.7/100 46.3/100 CRUS
Profit Margin 21.0% 9.3% CRUS
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY BUY CRUS

Relative Price Performance (Last 90 Days)

CRUS 1M: -7.8% · 3M: -16.9% MCHPP 1M: -1.0% · 3M: -4.9%

Current Technical Phase

CRUS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.8%), weak momentum, RSI 43

RSI (14): 43.3 · Price: $111.06

MCHPP

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -1.2%) with fading momentum, RSI 47

RSI (14): 46.7 · Price: $64.05

Fundamentals Snapshot

Metric CRUS MCHPP
Market Cap — —
Forward P/E 12.3 0.0
Trailing P/E 13.5 —
Revenue (TTM) — —
Revenue Growth 0.1% 0.4%
Gross Margin 0.5% 0.6%
Operating Margin 0.2% 0.2%
EPS 8.19 0.00
Dividend Yield — 0.03%

Frequently Asked Questions

Based on our detailed analysis, CRUS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.